HOME / ¹®¼¸¶ÄÏ / ³í¹® / ÀǾàÇкоß
°íÇ÷¾Ð¾à¹°Ä¡·áÀÇ ÃÖ½ÅÁö°ß ¿¬±¸³í¹®ÀÔ´Ï´Ù
Àüü 7 page Áß 1 page±îÁö ¹Ì¸®º¸±â°¡ °¡´ÉÇÕ´Ï´Ù.
¼Ò°³±Û
Á¦¸ñ : °íÇ÷¾Ð ¾à¹°Ä¡·áÀÇ ÃÖ½ÅÁö°ß
ÀúÀÚ : ¹ÚÇý¼÷
¹ßÇàÇÐȸ : Çѱ¹º¸°Ç±âÃÊÀÇÇÐȸ [The Korean Health & Fundamental Medical Science Society]
¹ßÇàÁ¤º¸ : Á¦ 8±Ç 1È£ pp.19-25(7 pages)
¹ßÇà³âµµ : 2015
ÀúÀ۽ñâ : 2015³â 6¿ù
¸ñÂ÷
¼ ·Ð
Ç÷¾ÐÀÇ ºÐ·ù¿Í °íÇ÷¾ÐÀÇ ±âÁØ
°íÇ÷¾Ð Ä¡·áÀÇ ¸ñÇ¥ Ç÷¾Ð
°íÇ÷¾ÐÄ¡·á¾àÁ¦ÀÇ ¼±ÅÃ
°á·Ð ¹× ³íÀÇ
Âü°í¹®Çå
º»¹®³»¿ë
Recently, a number of national
and international hypertension guidelines were updated. This review aims to compare the latest guidelines including NICE (2011), JNC8 (2013), ESH/ESC (2013), and Korean guideline (2013, KSH). In general, KSH is very similar to ESH/ESC on BP class, goal BP, and drug recommendations. All the guidelines have the same target of 140/90 mmHg for the general adult population and strict control in for the elderly is not consistently better than mild control, but, the definition of elderly varies between the guidelines and the recommendations for specific groups of patients (diabetes, or CKD). ESH/ESC and KSH recommend five specific medication classes including ACE-I or ARBs, CCB, DD, and BB to be used as initial therapy. NICE, on the other hand, recommends three specific medication except for BB and DD, and JNC8 recommends four drug classes except for BB. However, the physician¡¯s treatment decisions regarding the management of patients should consider an individual¡¯s clinical characteristics and circumstances using guidelines only as a framework. (ÀÌÇÏ »ý·«)
Âü°í¹®Çå
¾øÀ½
¹ÞÀº º°Á¡
0/5
0°³ÀÇ º°Á¡
¹®¼°øÀ¯ ÀڷḦ µî·ÏÇØ ÁÖ¼¼¿ä.
¹®¼°øÀ¯ Æ÷ÀÎÆ®¿Í Çö±ÝÀ» µå¸³´Ï´Ù.
Æ÷ÀÎÆ® : ÀÚ·á 1°Ç´ç ÃÖ´ë 5,000P Áö±Þ
Çö±Ý : ÀÚ·á 1°Ç´ç ÃÖ´ë 2,000¿ø Áö±Þ
ÀúÀÛ±Ç Á¤º¸
À§ Á¤º¸ ¹× °Ô½Ã¹° ³»¿ëÀÇ Áø½Ç¼º¿¡ ´ëÇÏ¿© ¾ÅÅ©Á¸Àº º¸ÁõÇÏÁö ¾Æ´ÏÇϸç, ÇØ´ç Á¤º¸ ¹× °Ô½Ã¹° ÀúÀ۱ǰú ±âŸ ¹ýÀû Ã¥ÀÓÀº ÀÚ·á µî·ÏÀÚ¿¡°Ô ÀÖ½À´Ï´Ù.
À§ Á¤º¸ ¹× °Ô½Ã¹° ³»¿ëÀÇ ºÒ¹ýÀû ÀÌ¿ë, ¹«´Ü ÀüÀ硤¹èÆ÷´Â ±ÝÁöµÇ¾î ÀÖ½À´Ï´Ù.
ÀúÀÛ±ÇħÇØ, ¸í¿¹ÈÑ¼Õ µî ºÐÀï¿ä¼Ò ¹ß°ß½Ã °í°´¼¾ÅÍÀÇ ÀúÀÛ±Ç Ä§ÇØ½Å°í¸¦ ÀÌ¿ëÇØ Áֽñ⠹ٶø´Ï´Ù.
ºê·£µå Á¤º¸
°í±Þ ³í¹®À» Á¦°øÇÏ´Â ÇÐÁö»ç ´º³í¹®Àº Àü¹® Çо÷ ºÐ¾ß¿¡ ÃÖ°íÀÇ ÀڷḦ º¸ÀåÇϸç
°¢Á¾ ¿¬±¸ »ç·Ê¿Í ¹Ì·¡ ºÐ¼® µîÀÇ ÀڷḦ ÅëÇØ Àι®ÇÐ, »çȸ ÀÚ¿¬°úÇÐ ºÐ¾ßÀÇ ±íÀÌ Àִ Ž»öÀ» ÇÒ ¼ö ÀÖ°Ô µµ¿Íµå¸®°Ú½À´Ï´Ù.
ÆǸÅÀÚ·á ¼ö : 32,704°Ç